Treatment of Pathological Gambling With Naltrexone Pharmacotherapy and Brief Intervention

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-01-31

Study Completion Date

2013-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this research is to explore the efficacy of the opiate antagonist, naltrexone as combined with CBT-intervention in the treatment of pathological gambling (PG). The study period is 2011-2014 during which one hundred Pathological Gamblers will be recruited to participate to this placebo-controlled double-blind trial.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Investigation of Naltrexone for Pathological Gambling

NCT01057862

Pathological Gambling

COMPLETED PHASE2

Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling

NCT00326807

Concurrent Alcohol Dependence and Pathological Gambling

COMPLETED NA

The Effect of Regular Naltrexone Dosing on Disordered Gamblers

NCT02537197

Gambling

COMPLETED PHASE1

Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder

NCT03430180

Pathological Gambling Gambling Disorder Opioid Antagonist +1 more

UNKNOWN PHASE2

Managing Alcoholism in People Who Do Not Respond to Naltrexone

NCT00115037

Alcoholism

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All participants have to be able to read and understand the patient information sheet and sign the informed consent. All participants are free to stop being in the study whenever they wanted. The patients are not paid or reimbursed for participation.

The study periods is 21 weeks during which the participant's have 8 appointments with the researchers. During the meetings research data will be collected and the participant is having Controlled Behavioral Therapy (CBT) consulting from a trained therapist. At the study visits, the subjects are given written instructions for the proper use of naltrexone and advised to take 50 mg naltrexone approximately one hour before gambling or feeling urges to gamble (and to refrain from taking naltrexone at other times). In this study the maximal daily dose is 50mg of naltrexone. The medication is free for the subjects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pathological Gambling

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo pill.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Placebo pill with no active ingredients.

50mg Naltrexone when needed

Group Type ACTIVE_COMPARATOR

Naltrexone pharmacotherapy

Intervention Type DRUG

Naltrexone 50mg when graving to gamble.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Naltrexone pharmacotherapy

Naltrexone 50mg when graving to gamble.

Intervention Type DRUG

Placebo

Placebo pill with no active ingredients.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pathological gambling (scores 5+ from SOGS-R and DSM-IV criteria)

Exclusion Criteria

* acute hepatitis
* severe liver or kidney dysfunction
* suicide risk or severe depression or other untreated mental health problem
* participation to other gambling research at the same time
* the use of drugs (especially opiates)
* pregnancy
* prisoners
* retarded and mentally ill patients were also excluded

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No